Brivaracetam Catalog No.:M10405-10 Formula: C29H32F3N5O3

Formula: C29H32F3N5O3

Ertugliflozin

Ketanserin inhibits the contractions of rat caudal arteries and canine saphenous veins caused by postjunctional alpha adrenergic activation

CAS Number: 1032900-25-6

Brivaracetam Catalog No.:M10405-10 Formula: C29H32F3N5O3Brivaracetam is discontinued (DEA controlled susbtance). Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam was approved in 2 18 2016 to treat partial onset seizures in patients age 16 years and older with epilepsy. This product is a controlled substance. Product information CAS Number: 357336 20 0